Recent news on Vivotif

Restructuring costs push Acambis into loss in 1Q; foundations laid ...  -  May 13, 2007
Silicon Fen Business Report,...main sources of revenue were from its fixed-price 155 million-dose smallpox contract with the CDC, our MVA3000 contracts and product sales of Vivotif.

Crucell announces fourth quarter and annual results 2006  -  Feb 12, 2007
Genetic Engineering News (press release),This sales and marketing organisation markets the Crucell's Vivotif oral vaccine in North America. * Acquisition of SBL Vaccin: In November 2006 Crucell

Crucell strengthens vaccine portfolio with SBL purchase  -  Nov 29, 2006
DrugResearcher.com,...recently acquired Florida-based Berna Products Corp (BPC) in October 2006, which gave them full control of the company's oral typhoid vaccine Vivotif.

Crucell Acquires SBL Vaccin For €40M Cash, Raises €80M  -  Nov 28, 2006
BioWorld Online,...based Berna Products Corp., which holds US marketing rights to an oral typhoid fever vaccine called Vivotif. (See BioWorld International, Oct. 4, 2006.)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional